Introducing KNECT: Upgrade Your KOL ID & Mapping Game with V2V’s Enhanced KOL ID Management Portal

KOL Profile

Filtering a spreadsheet to pinpoint the right expert can often feel like finding a needle in a haystack. You asked for a better solution. We listened. V2V is proud to announce our latest software application for visualizing data of Key Opinion Leader (KOL)/Key External Expert (KEE) Identification and Mapping projects.  

What is KNECT?

KNECT is our upgraded portal-based KOL ID & Mapping platform. This easy-to-navigate interface provides medical affairs, commercial, and clinical teams with unparalleled visibility into KOL/KEE’s influence patterns, all pulled from worldwide expert databases.

Social influence, clinical trials, publications, guideline influence, and more are available at your fingertips. KNECT eliminates the guesswork by providing comprehensive, validated intelligence on each expert. You’ll have confidence knowing that every data point has been verified and curated to ensure you’re connecting with truly credible thought leaders within your therapeutic area along with who they are connected to.

Customization and Scalability

We are fans of innovation. V2V’s in-house development team can also customize and scale the application to fit your business needs and rules, not the other way around.

KOL Profile

Key Features – Simple. Easy to Use. Customizable.

  • Detailed analysis and rankings for expert discovery within any therapeutic area
  • Rich datasets on KOLs (publications, trials, conferences, social media, associations) and more
  • Intuitive search and real-time visual mapping
  • Activity management and engagement tracking
  • Group management and collaboration
  • Social network analysis and influence mapping
  • Cloud-based, secure platform

Work smarter. Work faster. Work with KNECT.

Recent Posts

Speakers on a Shelf

Your Speaker’s Bureau Has a Shelf Life: Here’s How to Know When It Needs a Refresh

Nobody wants to be the last one to realize the shelf life of their milk has expired. Yet in biopharma marketing, it happens with speaker’s...

Read More
Globe with Pills

What’s Trending in BioPharma – March 2026

Europe risks falling behind in the global BioPharma race, the FDA is working to increase accessibility to personalized treatments in rare diseases, and regulators are...

Read More
Pills scattered on a table with money

What’s Trending in BioPharma – February 2026

The BioPharma industry is in rapid flux, shaped by transforming drug pipelines, the ongoing political battle over lowering drug prices, and a new rebate model...

Read More